戻る Agenda
Session 5: Safety Reporting – Guidance on Use of new RSI and Outstanding Issues
Session Chair(s)
Willemijn van der Spuij, MSc
Executive Director Europe | International - Patient Safety
Bristol Myers Squibb, Switzerland
Session 5: Safety Reporting – Guidance on Use of new RSI and Outstanding Issues
Speaker(s)
Regulators Perspective
Massimiliano Sarra, PhD, MPH
Italian Medicine Agency (AIFA), Italy
Permanent official and CTFG Secretary
Industry Perspective
Willemijn van der Spuij, MSc
Bristol Myers Squibb, Switzerland
Executive Director Europe | International - Patient Safety